Stay updated on Dupilumab for Eosinophilic Gastritis Clinical Trial

Sign up to get notified when there's something new on the Dupilumab for Eosinophilic Gastritis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dupilumab for Eosinophilic Gastritis Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-08T01:28:36.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.2, replacing v3.4.1, indicating a minor site update without changes to study details or enrollment information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-14T12:39:20.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Revision: v3.4.1 was added and Revision: v3.4.0 was removed.
    Difference
    0.1%
    Check dated 2026-02-07T08:27:44.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The page adds and removes several metadata and UI elements, including 'Show glossary', 'Results First Posted', and 'Last Update Posted', while older labels such as 'Results First Posted (Estimated)' are removed; capitalization adjustments (e.g., 'No FEAR Act Data') accompany the move to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-01-24T03:37:06.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Revision stamp updated to v3.3.4, replacing the previous v3.3.3.
    Difference
    0.1%
    Check dated 2026-01-17T01:55:24.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    Added a Locations section detailing the trial sites by state (Colorado, Illinois, Indiana, Massachusetts, New York, North Carolina, Ohio, Pennsylvania, Texas, Utah). Removed the separate Colorado Locations reference and HHS Vulnerability Disclosure.
    Difference
    1%
    Check dated 2025-12-19T13:09:18.000Z thumbnail image

Stay in the know with updates to Dupilumab for Eosinophilic Gastritis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dupilumab for Eosinophilic Gastritis Clinical Trial page.